Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Aker BioMarine ASA ( (DE:1PG) ) is now available.
Aker BioMarine ASA has completed and registered a share capital increase tied to its Employee Share Purchase Program with the Norwegian Register of Business Enterprises. The company’s new registered share capital is NOK 526,341,156, divided into 87,723,526 shares with a par value of NOK 6.00 each, and the additional shares will be listed on the Oslo Stock Exchange following registration in the Norwegian Central Securities Depository.
The transaction slightly expands Aker BioMarine’s equity base and free float, reinforcing employee ownership and aligning staff incentives more closely with shareholder interests. The move underscores the company’s continued use of equity-based compensation as a tool to support long-term commitment and may enhance liquidity in its shares on the Oslo market.
More about Aker BioMarine ASA
Aker BioMarine ASA is a Norwegian human health and nutrition company that develops krill-derived products from Antarctic waters for consumer health and nutrition markets. Its ingredient portfolio includes Superba Krill Oil, Lysoveta, Revervia and PL+, alongside the consumer brand Kori Krill, and it is listed on the Oslo Stock Exchange under the ticker AKBM.
Average Trading Volume: 33,640
Current Market Cap: NOK9.82B
See more data about 1PG stock on TipRanks’ Stock Analysis page.